| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |